Venus Concept (VERO) Competitors $2.33 +0.01 (+0.43%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.33 0.00 (0.00%) As of 09/12/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. CODX, SINT, STSS, LYRA, XAIR, DHAI, TNON, SSKN, PAVM, and LFWDShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Co-Diagnostics (CODX), Sintx Technologies (SINT), Sharps Technology (STSS), Lyra Therapeutics (LYRA), Beyond Air (XAIR), DIH Holding US (DHAI), Tenon Medical (TNON), Strata Skin Sciences (SSKN), PAVmed (PAVM), and Lifeward (LFWD). These companies are all part of the "medical equipment" industry. Venus Concept vs. Its Competitors Co-Diagnostics Sintx Technologies Sharps Technology Lyra Therapeutics Beyond Air DIH Holding US Tenon Medical Strata Skin Sciences PAVmed Lifeward Co-Diagnostics (NASDAQ:CODX) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment. Which has more volatility & risk, CODX or VERO? Co-Diagnostics has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CODX or VERO? 15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 8.4% of Co-Diagnostics shares are owned by insiders. Comparatively, 28.0% of Venus Concept shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is CODX or VERO more profitable? Venus Concept has a net margin of -68.77% compared to Co-Diagnostics' net margin of -3,588.33%. Co-Diagnostics' return on equity of -69.49% beat Venus Concept's return on equity.Company Net Margins Return on Equity Return on Assets Co-Diagnostics-3,588.33% -69.49% -60.49% Venus Concept -68.77%-871.77%-61.92% Do analysts prefer CODX or VERO? Co-Diagnostics currently has a consensus price target of $5.50, suggesting a potential upside of 1,512.43%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, equities analysts plainly believe Co-Diagnostics is more favorable than Venus Concept.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Venus Concept 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, CODX or VERO? Co-Diagnostics has higher earnings, but lower revenue than Venus Concept. Co-Diagnostics is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCo-Diagnostics$1.00M13.09-$37.64M-$1.15-0.30Venus Concept$60.11M0.06-$47M-$50.78-0.05 Does the media prefer CODX or VERO? In the previous week, Co-Diagnostics had 3 more articles in the media than Venus Concept. MarketBeat recorded 5 mentions for Co-Diagnostics and 2 mentions for Venus Concept. Venus Concept's average media sentiment score of 0.95 beat Co-Diagnostics' score of 0.18 indicating that Venus Concept is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Venus Concept 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCo-Diagnostics beats Venus Concept on 11 of the 17 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.32M$6.88B$5.85B$10.14BDividend YieldN/A1.21%5.68%4.60%P/E Ratio-0.0526.0175.3425.98Price / Sales0.06191.22514.55181.19Price / CashN/A22.1337.5660.44Price / Book0.545.0012.156.29Net Income-$47M$176.38M$3.29B$271.07M7 Day Performance2.19%1.00%0.74%3.87%1 Month Performance-4.51%0.74%4.82%4.88%1 Year Performance-61.13%10.34%60.58%26.12% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept1.2824 of 5 stars$2.33+0.4%N/A-63.1%$3.32M$60.11M-0.05410CODXCo-Diagnostics4.0632 of 5 stars$0.32-3.5%$5.50+1,629.6%-73.6%$12.25M$3.91M-0.28100News CoverageShort Interest ↑SINTSintx Technologies1.977 of 5 stars$4.47+7.6%$28.00+527.1%+25.4%$12.10M$2.89M-0.0940Gap UpSTSSSharps Technology0.7528 of 5 stars$11.75-13.3%N/AN/A$12.09MN/A-0.013Short Interest ↑Gap DownLYRALyra Therapeutics3.4067 of 5 stars$7.35+4.9%$100.00+1,261.5%-51.6%$12.05M$1.53M-0.2550Positive NewsXAIRBeyond Air4.4081 of 5 stars$2.23+0.5%$11.00+393.3%-69.0%$11.67M$3.70M-0.1970Short Interest ↓Gap UpDHAIDIH Holding US0.3872 of 5 stars$0.24-9.7%N/A-91.3%$11.27M$64.47M-0.79N/AShort Interest ↑Gap DownTNONTenon Medical2.1313 of 5 stars$1.25+0.4%$5.50+341.8%-73.0%$11.06M$3.28M-0.058Positive NewsShort Interest ↓SSKNStrata Skin Sciences2.6086 of 5 stars$2.55+7.1%$6.00+135.4%-51.8%$10.68M$33.56M-0.90120Short Interest ↑Gap DownHigh Trading VolumePAVMPAVmed4.2118 of 5 stars$0.48-2.1%$19.00+3,900.0%-75.6%$10.42M$2.99M0.4190News CoverageShort Interest ↑Gap UpLFWDLifeward2.6662 of 5 stars$0.62-2.6%$9.00+1,356.3%-82.1%$9.70M$25.66M-0.2060Short Interest ↓ Related Companies and Tools Related Companies CODX Alternatives SINT Alternatives STSS Alternatives LYRA Alternatives XAIR Alternatives DHAI Alternatives TNON Alternatives SSKN Alternatives PAVM Alternatives LFWD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
